CD138 - Revision history

Michael: /* Variable */

2016-08-09T15:10:58Z

Variable

← Older revision		Revision as of 15:10, 9 August 2016
Line 11:		Line 11:

	==Variable==		==Variable==
	*Adenocarcinoma - ~~esp.~~ gastrointestinal tract, female reproductive organs and breast.<ref name=pmid12866374/>		*Adenocarcinoma - often positive in primaries from gastrointestinal tract, female reproductive organs and breast.<ref name=pmid12866374/>

	==Negative==		==Negative==

Michael: /* Positive */

2016-08-09T15:10:29Z

Positive

← Older revision		Revision as of 15:10, 9 August 2016
Line 10:		Line 10:
	*[[Plasmacytoid urothelial carcinoma]].<ref name=pmid24246859>{{Cite journal \| last1 = Zhang \| first1 = W. \| last2 = Jiang \| first2 = YX. \| last3 = Liu \| first3 = Y. \| last4 = Yu \| first4 = WJ. \| last5 = Zhao \| first5 = H. \| last6 = Li \| first6 = YJ. \| title = [Plasmacytoid urothelial carcinoma of the urinary bladder: a clinicopathologic study of 16 cases]. \| journal = Zhonghua Bing Li Xue Za Zhi \| volume = 42 \| issue = 7 \| pages = 433-7 \| month = Jul \| year = 2013 \| doi = \| PMID = 24246859 }}</ref>		*[[Plasmacytoid urothelial carcinoma]].<ref name=pmid24246859>{{Cite journal \| last1 = Zhang \| first1 = W. \| last2 = Jiang \| first2 = YX. \| last3 = Liu \| first3 = Y. \| last4 = Yu \| first4 = WJ. \| last5 = Zhao \| first5 = H. \| last6 = Li \| first6 = YJ. \| title = [Plasmacytoid urothelial carcinoma of the urinary bladder: a clinicopathologic study of 16 cases]. \| journal = Zhonghua Bing Li Xue Za Zhi \| volume = 42 \| issue = 7 \| pages = 433-7 \| month = Jul \| year = 2013 \| doi = \| PMID = 24246859 }}</ref>

	==Variable		==Variable==
	*Adenocarcinoma - esp. gastrointestinal tract, female reproductive organs and breast.<ref name=pmid12866374/>		*Adenocarcinoma - esp. gastrointestinal tract, female reproductive organs and breast.<ref name=pmid12866374/>

Michael at 15:10, 9 August 2016

2016-08-09T15:10:24Z

← Older revision		Revision as of 15:10, 9 August 2016
Line 10:		Line 10:
	*[[Plasmacytoid urothelial carcinoma]].<ref name=pmid24246859>{{Cite journal \| last1 = Zhang \| first1 = W. \| last2 = Jiang \| first2 = YX. \| last3 = Liu \| first3 = Y. \| last4 = Yu \| first4 = WJ. \| last5 = Zhao \| first5 = H. \| last6 = Li \| first6 = YJ. \| title = [Plasmacytoid urothelial carcinoma of the urinary bladder: a clinicopathologic study of 16 cases]. \| journal = Zhonghua Bing Li Xue Za Zhi \| volume = 42 \| issue = 7 \| pages = 433-7 \| month = Jul \| year = 2013 \| doi = \| PMID = 24246859 }}</ref>		*[[Plasmacytoid urothelial carcinoma]].<ref name=pmid24246859>{{Cite journal \| last1 = Zhang \| first1 = W. \| last2 = Jiang \| first2 = YX. \| last3 = Liu \| first3 = Y. \| last4 = Yu \| first4 = WJ. \| last5 = Zhao \| first5 = H. \| last6 = Li \| first6 = YJ. \| title = [Plasmacytoid urothelial carcinoma of the urinary bladder: a clinicopathologic study of 16 cases]. \| journal = Zhonghua Bing Li Xue Za Zhi \| volume = 42 \| issue = 7 \| pages = 433-7 \| month = Jul \| year = 2013 \| doi = \| PMID = 24246859 }}</ref>

			==Variable
			*Adenocarcinoma - esp. gastrointestinal tract, female reproductive organs and breast.<ref name=pmid12866374/>

			==Negative==
			*[[Malignant mesothelioma]].<ref name=pmid12866374>{{Cite journal \| last1 = Chu \| first1 = PG. \| last2 = Arber \| first2 = DA. \| last3 = Weiss \| first3 = LM. \| title = Expression of T/NK-cell and plasma cell antigens in nonhematopoietic epithelioid neoplasms. An immunohistochemical study of 447 cases. \| journal = Am J Clin Pathol \| volume = 120 \| issue = 1 \| pages = 64-70 \| month = Jul \| year = 2003 \| doi = 10.1309/48KC-17WA-U69B-TBXQ \| PMID = 12866374 }}</ref>
	==See also==		==See also==
	*[[Plasma cell]].		*[[Plasma cell]].

Michael at 14:41, 8 December 2015

2015-12-08T14:41:30Z

← Older revision		Revision as of 14:41, 8 December 2015
Line 1:		Line 1:
	'''CD138''', also known as '''Syndecan-1''', is an [[immunostain]] that marks [[plasma cells]].		'''CD138''', also known as '''Syndecan-1''' (abbreviated '''SDC1'''),<ref name=omim186355>{{OMIM\|186355}}</ref> is an [[immunostain]] that marks [[plasma cells]].

			It plays a role in angiogenesis and cellular proliferation.<ref name=pmid26513873>{{Cite journal \| last1 = Guo \| first1 = Q. \| last2 = Yang \| first2 = X. \| last3 = Ma \| first3 = Y. \| last4 = Ma \| first4 = L. \| title = Syndecan-1 serves as a marker for the progression of epithelial ovarian carcinoma. \| journal = Eur J Gynaecol Oncol \| volume = 36 \| issue = 5 \| pages = 506-13 \| month = \| year = 2015 \| doi = \| PMID = 26513873 }}</ref>

	==Positive==		==Positive==

Michael at 14:36, 8 December 2015

2015-12-08T14:36:49Z

← Older revision		Revision as of 14:36, 8 December 2015
Line 6:		Line 6:
	*Triple negative breast cancer.<ref name=pmid25273930 >{{Cite journal \| last1 = Lim \| first1 = GH. \| last2 = Tan \| first2 = PH. \| last3 = Jara-Lazaro \| first3 = AR. \| last4 = Thike \| first4 = AA. \| last5 = Sim \| first5 = WC. \| last6 = Yap \| first6 = VB. \| last7 = Yip \| first7 = GW. \| title = Syndecan-1 is a potential biomarker for triple-positive breast carcinomas in Asian women with correlation to survival. \| journal = Singapore Med J \| volume = 55 \| issue = 9 \| pages = 468-72 \| month = Sep \| year = 2014 \| doi = \| PMID = 25273930 }}		*Triple negative breast cancer.<ref name=pmid25273930 >{{Cite journal \| last1 = Lim \| first1 = GH. \| last2 = Tan \| first2 = PH. \| last3 = Jara-Lazaro \| first3 = AR. \| last4 = Thike \| first4 = AA. \| last5 = Sim \| first5 = WC. \| last6 = Yap \| first6 = VB. \| last7 = Yip \| first7 = GW. \| title = Syndecan-1 is a potential biomarker for triple-positive breast carcinomas in Asian women with correlation to survival. \| journal = Singapore Med J \| volume = 55 \| issue = 9 \| pages = 468-72 \| month = Sep \| year = 2014 \| doi = \| PMID = 25273930 }}
	</ref>		</ref>
			*[[Plasmacytoid urothelial carcinoma]].<ref name=pmid24246859>{{Cite journal \| last1 = Zhang \| first1 = W. \| last2 = Jiang \| first2 = YX. \| last3 = Liu \| first3 = Y. \| last4 = Yu \| first4 = WJ. \| last5 = Zhao \| first5 = H. \| last6 = Li \| first6 = YJ. \| title = [Plasmacytoid urothelial carcinoma of the urinary bladder: a clinicopathologic study of 16 cases]. \| journal = Zhonghua Bing Li Xue Za Zhi \| volume = 42 \| issue = 7 \| pages = 433-7 \| month = Jul \| year = 2013 \| doi = \| PMID = 24246859 }}</ref>

	==See also==		==See also==
	*[[Plasma cell]].		*[[Plasma cell]].

	==References==		==References==
	{{Reflist\|1}}		{{Reflist\|2}}

	[[Category:Immunohistochemistry]].		[[Category:Immunohistochemistry]].

Michael at 14:35, 8 December 2015

2015-12-08T14:35:55Z

← Older revision		Revision as of 14:35, 8 December 2015
Line 6:		Line 6:
	*Triple negative breast cancer.<ref name=pmid25273930 >{{Cite journal \| last1 = Lim \| first1 = GH. \| last2 = Tan \| first2 = PH. \| last3 = Jara-Lazaro \| first3 = AR. \| last4 = Thike \| first4 = AA. \| last5 = Sim \| first5 = WC. \| last6 = Yap \| first6 = VB. \| last7 = Yip \| first7 = GW. \| title = Syndecan-1 is a potential biomarker for triple-positive breast carcinomas in Asian women with correlation to survival. \| journal = Singapore Med J \| volume = 55 \| issue = 9 \| pages = 468-72 \| month = Sep \| year = 2014 \| doi = \| PMID = 25273930 }}		*Triple negative breast cancer.<ref name=pmid25273930 >{{Cite journal \| last1 = Lim \| first1 = GH. \| last2 = Tan \| first2 = PH. \| last3 = Jara-Lazaro \| first3 = AR. \| last4 = Thike \| first4 = AA. \| last5 = Sim \| first5 = WC. \| last6 = Yap \| first6 = VB. \| last7 = Yip \| first7 = GW. \| title = Syndecan-1 is a potential biomarker for triple-positive breast carcinomas in Asian women with correlation to survival. \| journal = Singapore Med J \| volume = 55 \| issue = 9 \| pages = 468-72 \| month = Sep \| year = 2014 \| doi = \| PMID = 25273930 }}
	</ref>		</ref>

	==See also==		==See also==
	*[[Plasma cell]].		*[[Plasma cell]].

Michael: /* Positive */

2015-12-08T14:35:43Z

Positive

← Older revision		Revision as of 14:35, 8 December 2015
Line 2:		Line 2:

	==Positive==		==Positive==
	*[[Plasma cell]]s.		*[[Plasma cell]]s.<ref name=Ref_WMSP554>{{Ref WMSP\|554}}</ref>
	*[[Plasma cell neoplasm]].		*[[Plasma cell neoplasm]].
	*Triple negative breast cancer.<ref name=pmid25273930 >{{Cite journal \| last1 = Lim \| first1 = GH. \| last2 = Tan \| first2 = PH. \| last3 = Jara-Lazaro \| first3 = AR. \| last4 = Thike \| first4 = AA. \| last5 = Sim \| first5 = WC. \| last6 = Yap \| first6 = VB. \| last7 = Yip \| first7 = GW. \| title = Syndecan-1 is a potential biomarker for triple-positive breast carcinomas in Asian women with correlation to survival. \| journal = Singapore Med J \| volume = 55 \| issue = 9 \| pages = 468-72 \| month = Sep \| year = 2014 \| doi = \| PMID = 25273930 }}		*Triple negative breast cancer.<ref name=pmid25273930 >{{Cite journal \| last1 = Lim \| first1 = GH. \| last2 = Tan \| first2 = PH. \| last3 = Jara-Lazaro \| first3 = AR. \| last4 = Thike \| first4 = AA. \| last5 = Sim \| first5 = WC. \| last6 = Yap \| first6 = VB. \| last7 = Yip \| first7 = GW. \| title = Syndecan-1 is a potential biomarker for triple-positive breast carcinomas in Asian women with correlation to survival. \| journal = Singapore Med J \| volume = 55 \| issue = 9 \| pages = 468-72 \| month = Sep \| year = 2014 \| doi = \| PMID = 25273930 }}

Michael: create

2015-12-08T14:34:46Z

create

New page

'''CD138''', also known as '''Syndecan-1''', is an [[immunostain]] that marks [[plasma cells]].

==Positive==
*[[Plasma cell]]s.
*[[Plasma cell neoplasm]].
*Triple negative breast cancer.<ref name=pmid25273930 >{{Cite journal | last1 = Lim | first1 = GH. | last2 = Tan | first2 = PH. | last3 = Jara-Lazaro | first3 = AR. | last4 = Thike | first4 = AA. | last5 = Sim | first5 = WC. | last6 = Yap | first6 = VB. | last7 = Yip | first7 = GW. | title = Syndecan-1 is a potential biomarker for triple-positive breast carcinomas in Asian women with correlation to survival. | journal = Singapore Med J | volume = 55 | issue = 9 | pages = 468-72 | month = Sep | year = 2014 | doi = | PMID = 25273930 }}
</ref>

==See also==
*[[Plasma cell]].

==References==
{{Reflist|1}}

[[Category:Immunohistochemistry]].